PainChek 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for PainChek.

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare Services 収益成長	20.9%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

May 07

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Nov 20

Recent updates

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、PainChek は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

ASX:PCK - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	3	-8	-7	-7	N/A
3/31/2024	3	-8	-7	-7	N/A
12/31/2023	2	-8	-6	-6	N/A
9/30/2023	2	-8	-6	-6	N/A
6/30/2023	2	-8	-6	-6	N/A
3/31/2023	2	-7	-6	-6	N/A
12/31/2022	1	-7	-6	-6	N/A
9/30/2022	1	-6	-6	-6	N/A
6/30/2022	1	-6	-7	-7	N/A
3/31/2022	1	-6	-7	-7	N/A
12/31/2021	0	-7	-6	-6	N/A
9/30/2021	0	-6	-5	-5	N/A
6/30/2021	0	-6	-4	-4	N/A
3/31/2021	0	-5	-4	-3	N/A
12/31/2020	0	-4	-3	-3	N/A
9/30/2020	0	-8	-2	-2	N/A
6/30/2020	0	-12	-2	-2	N/A
3/31/2020	0	-12	-3	-3	N/A
12/31/2019	0	-12	-4	-4	N/A
9/30/2019	0	-8	-4	-4	N/A
6/30/2019	0	-3	-3	-3	N/A
3/31/2019	0	-3	-3	-3	N/A
12/31/2018	0	-3	-3	-3	N/A
9/30/2018	0	-4	-3	-3	N/A
6/30/2018	0	-5	-3	-3	N/A
3/31/2018	0	-5	N/A	-3	N/A
12/31/2017	0	-5	N/A	-3	N/A
9/30/2017	0	-7	N/A	-2	N/A
6/30/2017	0	-8	N/A	-2	N/A
6/30/2016	0	0	N/A	0	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if PCK's forecast earnings growth is above the savings rate (2.4%).

収益対市場: Insufficient data to determine if PCK's earnings are forecast to grow faster than the Australian market

高成長収益: Insufficient data to determine if PCK's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if PCK's revenue is forecast to grow faster than the Australian market.

高い収益成長: Insufficient data to determine if PCK's revenue is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Insufficient data to determine if PCK's Return on Equity is forecast to be high in 3 years time

PainChek 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Forecast to breakeven in 2025

Consensus forecasts updated

Consensus forecasts updated

Forecast breakeven date pushed back to 2024

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Recent updates

PainChek Limited to Report Q4, 2024 Results on Oct 30, 2024

PainChek Limited, Annual General Meeting, Nov 28, 2024

Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.006 loss in FY 2023)

PainChek Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.

PainChek Limited Announces Change of Company Secretary

PainChek Limited has completed a Follow-on Equity Offering in the amount of AUD 3.55 million.

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

New minor risk - Shareholder dilution

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

PainChek Limited, Annual General Meeting, Nov 22, 2023

New minor risk - Financial data availability

New minor risk - Share price stability

We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Is PainChek (ASX:PCK) In A Good Position To Invest In Growth?

PainChek Limited Announces Company Secretary Changes

No independent directors

PainChek Limited, Annual General Meeting, Nov 23, 2022

Forecast to breakeven in 2025

Painchek Limited to Receive Govt Funding for Children's Disability App

Will PainChek (ASX:PCK) Spend Its Cash Wisely?

Consensus forecasts updated

No independent directors

PainChek Ltd Appoints Cynthia Payne as Non-Executive Director, Effective 30 March 2022

Consensus forecasts updated

Forecast breakeven date pushed back to 2024

Companies Like PainChek (ASX:PCK) Can Afford To Invest In Growth

We're Interested To See How PainChek (ASX:PCK) Uses Its Cash Hoard To Grow

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.013 loss in FY 2020)

PainChek Limited Infant Achieves International Regulatory Clearances

When Can We Expect A Profit From PainChek Limited (ASX:PCK)?

PainChek (ASX:PCK) Is In A Strong Position To Grow Its Business

PainChek Limited Announces Successful Completion of Infant Face-Only Clinical Study

Market Sentiment Around Loss-Making PainChek Limited (ASX:PCK)

Full year earnings released - AU$0.013 loss per share

PainChek Ltd. announced that it expects to receive AUD 10 million in funding

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘